Dimensional Fund Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$73.7M Sell
5,323,248
-33,913
-0.6% -$472K 0.02% 1278
2025
Q4
$75.2M Buy
5,357,161
+4,274
+0.1% +$60K 0.02% 1273
2025
Q3
$74.8M Sell
5,352,887
-47,643
-0.9% -$686K 0.02% 1278
2025
Q2
$81.2M Sell
5,400,530
-64,081
-1% -$915K 0.02% 1173
2025
Q1
$72.1M Buy
5,464,611
+103,598
+2% +$1.43M 0.02% 1222
2024
Q4
$84.6M Buy
5,361,013
+62,008
+1% +$932K 0.02% 1172
2024
Q3
$84.2M Buy
5,299,005
+280,095
+6% +$4.51M 0.02% 1170
2024
Q2
$76.5M Buy
5,018,910
+571,470
+13% +$8.19M 0.02% 1171
2024
Q1
$65.2M Buy
4,447,440
+300,890
+7% +$4.39M 0.02% 1272
2023
Q4
$57.7M Buy
4,146,550
+9,095
+0.2% +$122K 0.02% 1339
2023
Q3
$55.3M Sell
4,137,455
-14,900
-0.4% -$202K 0.02% 1268
2023
Q2
$52.4M Sell
4,152,355
-123,755
-3% -$1.44M 0.02% 1330
2023
Q1
$48.7M Sell
4,276,110
-82,820
-2% -$894K 0.02% 1342
2022
Q4
$45.1K Buy
4,358,930
+174,245
+4% +$1.88M 0.01% 1386
2022
Q3
$43.8M Buy
4,184,685
+359,355
+9% +$3.83M 0.02% 1331
2022
Q2
$42.4M Buy
3,825,330
+522,270
+16% +$5.68M 0.02% 1412
2022
Q1
$36.8M Buy
3,303,060
+393,815
+14% +$4.46M 0.01% 1622
2021
Q4
$38.1M Buy
2,909,245
+132,160
+5% +$1.67M 0.01% 1604
2021
Q3
$36.2M Buy
2,777,085
+107,585
+4% +$1.43M 0.01% 1656
2021
Q2
$39.2M Sell
2,669,500
-198,690
-7% -$2.78M 0.01% 1624
2021
Q1
$35.2M Sell
2,868,190
-66,090
-2% -$849K 0.01% 1703
2020
Q4
$41.8M Sell
2,934,280
-644,600
-18% -$8.68M 0.02% 1516
2020
Q3
$49.8M Sell
3,578,880
-486,125
-12% -$5.79M 0.02% 1207
2020
Q2
$43.1M Sell
4,065,005
-314,120
-7% -$3.2M 0.02% 1327
2020
Q1
$35.3M Sell
4,379,125
-302,970
-6% -$2.53M 0.02% 1336
2019
Q4
$38M Sell
4,682,095
-71,350
-2% -$563K 0.01% 1667
2019
Q3
$36.1M Buy
4,753,445
+28,480
+0.6% +$212K 0.01% 1657
2019
Q2
$35.4M Buy
4,724,965
+4,400
+0.1% +$34.6K 0.01% 1715
2019
Q1
$38.2M Buy
4,720,565
+112,125
+2% +$852K 0.02% 1646
2018
Q4
$34.8M Buy
4,608,440
+16,360
+0.4% +$115K 0.02% 1609
2018
Q3
$31.8M Buy
4,592,080
+412,945
+10% +$2.76M 0.01% 1853
2018
Q2
$26.9M Buy
4,179,135
+712,460
+21% +$4.49M 0.01% 1944
2018
Q1
$22.7M Buy
3,466,675
+552,155
+19% +$3.87M 0.01% 1991
2017
Q4
$21.9M Buy
2,914,520
+4,830
+0.2% +$34.8K 0.01% 2017
2017
Q3
$20.8M Buy
2,909,690
+41,000
+1% +$295K 0.01% 2030
2017
Q2
$24.2M Buy
2,868,690
+20,810
+0.7% +$169K 0.01% 1915
2017
Q1
$22.9M Sell
2,847,880
-343,695
-11% -$2.97M 0.01% 1909
2016
Q4
$28.9M Sell
3,191,575
-11,505
-0.4% -$107K 0.01% 1679
2016
Q3
$29.7M Sell
3,203,080
-17,365
-0.5% -$166K 0.02% 1582
2016
Q2
$33M Sell
3,220,445
-233,025
-7% -$2.14M 0.02% 1413
2016
Q1
$31.2M Buy
3,453,470
+176,695
+5% +$1.58M 0.02% 1421
2015
Q4
$30.3M Buy
3,276,775
+158,570
+5% +$1.74M 0.02% 1381
2015
Q3
$39.8M Buy
3,118,205
+191,120
+7% +$2.37M 0.03% 1028
2015
Q2
$32.4M Buy
2,927,085
+301,915
+12% +$3.33M 0.02% 1353
2015
Q1
$29.9M Buy
2,625,170
+629,505
+32% +$6.68M 0.02% 1388
2014
Q4
$20.1M Buy
1,995,665
+365,720
+22% +$3.85M 0.01% 1736
2014
Q3
$17.1M Sell
1,629,945
-9,000
-0.5% -$84.6K 0.01% 1797
2014
Q2
$14.1M Buy
1,638,945
+31,385
+2% +$264K 0.01% 1958
2014
Q1
$14.1M Sell
1,607,560
-27,415
-2% -$238K 0.01% 1903
2013
Q4
$13.4M Sell
1,634,975
-1,920
-0.1% -$15.2K 0.01% 1925
2013
Q3
$12.4M Buy
1,636,895
+23,380
+1% +$170K 0.01% 1913
2013
Q2
$12.2M Buy
+1,613,515
New +$11.8M 0.01% 1832

Other funds holding RDY

Dimensional Fund Advisors's RDY Position: Q1 2026 in Review

Dimensional Fund Advisors reduced its Dr. Reddy's Laboratories (RDY) stake by 0.63% in Q1 2026, selling an estimated $472K and leaving 5,323,248 shares worth $73.7M. The position accounts for 0.02% of the portfolio, ranked #1278.

Dimensional Fund Advisors first reported a position in RDY in Q2 2013 and has held it in 52 quarters since. The position peaked at $84.6M in Q4 2024. 248 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • Dimensional Fund Advisors held 5,323,248 shares of Dr. Reddy's Laboratories worth $73.7M as of Q1 2026.
  • Dimensional Fund Advisors sold 33,913 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $472K.
  • Dr. Reddy's Laboratories made up 0.02% of Dimensional Fund Advisors's portfolio in Q1 2026, its #1278 holding.
  • Dimensional Fund Advisors first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Dimensional Fund Advisors's Dr. Reddy's Laboratories position peaked at $84.6M in Q4 2024.
  • 248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.